K-STREET TRACKER
FOLLOW THE MONEY INTO THE SWAMP
Every federal lobbying filing tagged with a public-company ticker — who is spending, which firms they hire, and which members trade right around the filing.
Filings tracked
19,882
thru 2026-05-08
Total reported $
$2.7B
disclosed lobbying
Distinct clients
2,220
paying companies
Tickers targeted
1,207
public companies
💸 Top Spending Clients
| # | Client | Filings | Total $ |
|---|---|---|---|
| 1 |  PFIZER INC.PFE | 47 | $46.8M |
| 2 |  GENERAL MOTORS COMPANYGM | 61 | $46.8M |
| 3 |  META PLATFORMS INC. AND VARIOUS SUBSIDIARIESMETA | 12 | $44.9M |
| 4 | VISA INC.V | 45 | $37.7M |
| 5 |  AMAZON.COM SERVICES LLCAMZN | 36 | $32.8M |
| 6 |  LOCKHEED MARTIN CORPORATIONLMT | 73 | $29.0M |
| 7 |  FEDEX CORPORATIONFDX | 69 | $27.8M |
| 8 |  ELI LILLY AND COMPANYLLY | 56 | $27.1M |
| 9 |  ALTRIA CLIENT SERVICES LLCMO | 142 | $25.2M |
| 10 |  AMGEN INCAMGN | 19 | $24.9M |
| 11 |  COMCAST CORPORATIONCMCSV | 179 | $24.7M |
| 12 |  MERCK & CO INCMRK | 14 | $24.0M |
| 13 |  SOUTHERN COMPANYSO | 53 | $23.9M |
| 14 |  GOOGLE CLIENT SERVICES LLCGOOGL | 79 | $22.6M |
| 15 |  APPLE INCAAPL | 9 | $22.1M |
| 16 |  T-MOBILE USA INC.TMUS | 121 | $21.0M |
| 17 |  UNITEDHEALTH GROUP INCUNH | 19 | $20.4M |
| 18 |  VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIESVZ | 40 | $20.1M |
| 19 |  OCCIDENTAL PETROLEUM CORPORATIONOXY | 30 | $19.7M |
| 20 |  MICROSOFT CORPORATIONMSFT | 103 | $18.8M |
| 21 |  QUALCOMM INCORPORATEDQCOM | 40 | $17.2M |
| 22 |  GENERAL DYNAMICS CORPGD | 11 | $17.0M |
| 23 |  BOEING COMPANYBA | 23 | $16.9M |
| 24 | THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)CI | 13 | $16.9M |
| 25 |  ORACLE CORPORATIONORCL | 58 | $16.7M |
🎯 Top Lobbied Tickers
| # | Ticker | Filings | Total $ |
|---|---|---|---|
| 1 | META Meta Platforms Inc. | 129 | $50.2M |
| 2 | PFE Pfizer Inc. | 87 | $48.6M |
| 3 | GM General Motors Company | 103 | $48.4M |
| 4 | V Visa Inc. | 46 | $37.7M |
| 5 | AMZN Amazon.com Inc. | 80 | $35.3M |
| 6 | LMT Lockheed Martin Corporation | 88 | $29.4M |
| 7 | FDX FedEx Corporation | 82 | $28.3M |
| 8 | LLY Eli Lilly and Company | 83 | $28.1M |
| 9 | AMGN Amgen Inc. | 95 | $28.0M |
| 10 | MRK Merck & Co. Inc. | 92 | $27.5M |
| 11 | AAPL Apple Inc. | 64 | $26.8M |
| 12 | GOOGL Alphabet Inc. Class A | 123 | $26.6M |
| 13 | MO | 164 | $26.2M |
| 14 | SO Southern Company | 108 | $26.1M |
| 15 | UNH UnitedHealth Group Inc. | 67 | $23.9M |
| 16 | VZ Verizon Communications Inc. | 116 | $23.8M |
| 17 | TMUS | 159 | $22.7M |
| 18 |  CHTR | 137 | $22.6M |
| 19 | GD General Dynamics Corporation | 127 | $22.5M |
| 20 |  TAT&T Inc. | 134 | $21.6M |
| 21 | ORCL Oracle Corporation | 132 | $20.6M |
| 22 | CMCSA Comcast Corporation | 141 | $20.4M |
| 23 | CI The Cigna Group | 64 | $19.9M |
| 24 | OXY Occidental Petroleum Corporation | 36 | $19.9M |
| 25 | MSFT Microsoft Corporation | 122 | $19.2M |
🆕 Filtered Filings · CIGNA CORPORATION AND SUBSIDIARIES
clear filters| Date | Ticker | Client | Registrant | Amount | Issue |
|---|---|---|---|---|---|
| 2026-04-20 | CI | CIGNA CORPORATION AND SUBSIDIARIES | TIBER CREEK GROUP | $90K | Issues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260). Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60). Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act. |
| 2026-01-17 | CI | CIGNA CORPORATION AND SUBSIDIARIES | TIBER CREEK GROUP | $90K | Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy; Issues related to the continuation of telehealth flexibilities. Issues related to proposals impacting employer-sponsored insurance; Issues related to pharmacy and prescription drug pricing policy; Issues related to H.R. 247/S. 846 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169). Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60). |
| 2025-10-19 | CI | CIGNA CORPORATION AND SUBSIDIARIES | TIBER CREEK GROUP | $90K | Issues related to Medicare drug coverage, specialty pharmacy, and general prescription drug pricing policy. Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability; Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21); Issues related to competition in the health care marketplace. Pharmacy issues related to H.R. 3838 - Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026; Pharmacy issues related to S. 2296 - National Defense Authorization Act for Fiscal Year 2026. |
| 2025-07-20 | CI | CIGNA CORPORATION AND SUBSIDIARIES | TIBER CREEK GROUP | $90K | Issues related to pharmacy, Medicare Part D, and prescription drug pricing policy. Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability. Issues related to tax and health coverage changes in the One Big Beautiful Bill Act (PL 119-21). Pharmacy issues related to TRICARE. |
| 2025-04-20 | CI | CIGNA CORPORATION AND SUBSIDIARIES | TIBER CREEK GROUP | $90K | Issues related to pharmacy, Medicare Part D, and prescription drug pricing policy. Issues related to proposals impacting employer sponsored insurance; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth; Issues related to an extension of enhanced premium tax credits and health insurance affordability. Pharmacy issues related to TRICARE. |
| 2025-01-19 | CI | CIGNA CORPORATION AND SUBSIDIARIES | TIBER CREEK GROUP | $90K | Proposals impacting employer sponsored insurance, Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy and telehealth in H.R.5378 - Lower Cost, More Transparency Act; H.R.10545 - American Relief Act of 2025 (PL 118-158). Pharmacy issues related to TRICARE in H.R. 8070 - Service Quality of Life Improvement and National Defense Authorization Act of Fiscal Year 2025. Issues related to pharmacy and prescription drug pricing policy in H.R.5378 - Lower Cost, More Transparency Act, and H.R.10545 - American Relief Act of 2025 (PL 118-158). |